Samsara BioCapital, LLC - MILLENDO THERAPEUTICS INC ownership

MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 72 filers reported holding MILLENDO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 9.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of MILLENDO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$3,967,000
-17.7%
751,301
+5.0%
2.28%
-1.1%
Q4 2019$4,820,000
+263.5%
715,201
+283.4%
2.31%
+155.7%
Q3 2019$1,326,000
+154.5%
186,540
+313.6%
0.90%
+162.5%
Q2 2019$521,000
-23.0%
45,1010.0%0.34%
-35.3%
Q1 2019$677,000
+88.6%
45,1010.0%0.53%
+54.2%
Q4 2018$359,00045,1010.34%
Other shareholders
MILLENDO THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 715,201$4,820,0002.31%
FRAZIER MANAGEMENT LLC 1,396,615$9,413,0001.58%
GREAT POINT PARTNERS LLC 1,729,759$11,659,0001.02%
Monashee Investment Management LLC 140,168$945,0000.88%
Bpifrance SA 1,078,670$7,270,0000.84%
AWM Investment Company, Inc. 611,900$4,124,0000.81%
NEA Management Company, LLC 1,766,779$11,908,0000.56%
ADAMS STREET PARTNERS LLC 312,279$2,105,0000.43%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 177,825$1,191,0000.43%
DAFNA Capital Management LLC 129,525$873,0000.30%
View complete list of MILLENDO THERAPEUTICS INC shareholders